Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma
Clinical trial NCT04002401 · COMPLETED
Trial details
- NCT number
- NCT04002401
- Sponsor
- Kite, A Gilead Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-05
- Primary completion
- 2023-01-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.